Cart
sales@molnova.com
CP-724714 (b)
CAS No. 537705-08-1
CP-724714 (b)( —— )
Catalog No. M14915 CAS No. 537705-08-1
CP-724714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 50MG | 1782 | In Stock |
|
| 100MG | 2250 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCP-724714 (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionCP-724714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM.
-
DescriptionCP-724714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM, >640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met etc in cell-free assays. Phase 2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorHER2/ErbB2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number537705-08-1
-
Formula Weight469.53
-
Molecular FormulaC27H27N5O3
-
Purity>98% (HPLC)
-
SolubilityN/A
-
SMILESCCOC(=O)NC/C=C/C1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OC4=CN=C(C=C4)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1 Jani JP, et al. Cancer Res, 2007, 67(20), 9887-9893.
2 Feng B, et al. Toxicol Sci, 2009, 108(2), 492-500.
molnova catalog
related products
-
AG18
AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
-
Petosemtamab
Petosemtamab (MCLA 158) is a highly potent monoclonal antibody against EGFR (Kd: 0.22 nM) and LGR5 (Kd: 0.86 nM). Petosemtamab promotes EGFR signaling disruption and receptor breakdown in LGR5+ cancer cells.
-
Epimedin B
Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.
